Eleven patients with B-ALL or LBCL had quantitative flow cytometry at progression; 6 patients had low CD19 with ≤3,000 molecules per cell (Fig. 4d), including 1 patient with LBCL with a CD19 H-score >150. Here, CD19 is linked to acute lymphoblastic leukemia.